Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Research & Development (2020 - 2025)

Historic Research & Development for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to $69.4 million.

  • Ginkgo Bioworks Holdings' Research & Development fell 993.82% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.0 million, marking a year-over-year decrease of 4189.58%. This contributed to the annual value of $424.1 million for FY2024, which is 2696.42% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Research & Development of $69.4 million as of Q3 2025, which was down 993.82% from $53.4 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Research & Development's 5-year high stood at $985.0 million during Q4 2021, with a 5-year trough of $52.0 million in Q2 2021.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Research & Development value was $134.2 million (recorded in 2024), while the average stood at $179.0 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Research & Development soared by 150975.47% in 2021 and then crashed by 8197.53% in 2022.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Research & Development stood at $985.0 million in 2021, then tumbled by 81.98% to $177.5 million in 2022, then crashed by 34.08% to $117.0 million in 2023, then crashed by 34.74% to $76.4 million in 2024, then fell by 9.2% to $69.4 million in 2025.
  • Its last three reported values are $69.4 million in Q3 2025, $53.4 million for Q2 2025, and $70.9 million during Q1 2025.